The osmotic fragility of erythrocytes was studied in 24 patients receiving whole-body hyperthermia, with and without concomitant chemotherapy, for 2-4 hours as an adjuvant to chemotherapy for advanced metastatic disease. No alteration in osmotic fragility of erythrocytes was observed with whole-body hyperthermia.
|Number of pages||2|
|Journal||Cancer Treatment Reports|
|Publication status||Published - Dec 1 1981|
ASJC Scopus subject areas
- Cancer Research